IMR Press / FBL / Volume 4 / Issue 4 / DOI: 10.2741/klint

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Signal transduction by fibroblast growth factor receptors
Show Less
1 Dept. of Med. Biochemistry and Microbiology, Biomedical Center, Box 575, S-751 23 Uppsala, Sweden
Academic Editor:Andrius Kazlauskas
Front. Biosci. (Landmark Ed) 1999, 4(4), 165–177;
Published: 15 February 1999
(This article belongs to the Special Issue Signaling through protein kinase C)

The fibroblast growth factor family, with its prototype members acidic FGF (FGF-1) and basic FGF (FGF-2), binds to four related receptor tyrosine kinases, expressed on most types of cells in tissue culture. In many respects, the FGF receptors appear similar to other growth factor receptors. Thus, dimerization of receptor monomers upon ligand binding is likely to be a requisite for activation of the kinase domains, leading to receptor trans phosphorylation. FGF receptor-1 (FGFR-1), which shows the broadest expression pattern of the four FGF receptors contains at least seven tyrosine phosphorylation sites. A number of signal transduction molecules are affected by binding with different affinities to these phosphorylation sites. The potential roles of these signal transduction molecules in FGF-induced biological responses and in pathological processes are discussed.

Signal transduction
FGF receptors
SH2 domain
Back to top